John P. Sharp
2008 - Ligand Pharmaceuticals
In 2008, John P. Sharp earned a total compensation of $499.9K as Vice President, Finance and Chief Financial Officer at Ligand Pharmaceuticals, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $61,400 |
|---|---|
| Option Awards | $91,105 |
| Salary | $255,833 |
| Stock Awards | $88,995 |
| Other | $2,532 |
| Total | $499,865 |
Sharp received $255.8K in salary, accounting for 51% of the total pay in 2008.
Sharp also received $61.4K in non-equity incentive plan, $91.1K in option awards, $89K in stock awards and $2.5K in other compensation.
Rankings
In 2008, John P. Sharp's compensation ranked 6,502nd out of 9,135 executives tracked by ExecPay. In other words, Sharp earned more than 28.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,502 out of 9,135 | 29th |
Division Manufacturing | 2,412 out of 3,436 | 30th |
Major group Chemicals And Allied Products | 534 out of 815 | 35th |
Industry group Drugs | 364 out of 597 | 39th |
Industry Pharmaceutical Preparations | 269 out of 408 | 34th |
Source: SEC filing on April 29, 2009.
Sharp's colleagues
We found four more compensation records of executives who worked with John P. Sharp at Ligand Pharmaceuticals in 2008.
2008
John Higgins
Ligand Pharmaceuticals
Chief Executive Officer
2008
Martin Meglasson
Ligand Pharmaceuticals
Vice President, Discovery Research
2008
Zofia Dziewanowska
Ligand Pharmaceuticals
Vice President, Clinical Research and Regulatory
2008
Charles Berkman
Ligand Pharmaceuticals